Trademarkia Logo

Canada

C$
TYCRUVA & DESIGN
REGISTERED

on 12 Jan 2024

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB COMPANY

Route 206 & Province Line RoadPrinceton, NJ 08543

US

Serial Number

2142535 filed on 25th Oct 2021

Registration Number

TMA1218203 registered on 12th Jan 2024

Registration expiry Date

12th Jan 2034

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

TYCRUVA & DESIGN

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosi Read More

Vienna Information


3 . 7 . 17

Wings, stylized or not -- Notes: (a) Including wings constituting a symbol or an emblem. -- (b) Not including wheels or wheel segments with wings (15.7.17), staves with wings (24.11.3) and Mercury's helmet (with wings) (24.11.14).Ailes, stylisées ou non -- Notes: (a) Y compris les ailes constituant un symbole ou un emblème. -- (b) Non compris les roues ou segments de roues ailés (15.7.17), les bâtons avec ailes (24.11.3) et le casque ailé de Mercure (24.11.14).

3 . 13 . 1

ButterfliesPapillons

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 15

Two to four leavesDeux à quatre feuilles

26 . 2 . 3

Sectors of circles or ellipses (except 26.2.7)Secteurs de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 6

Triangular figures with one or more convex or concave sidesFigures triangulaires à un ou plusieurs côtés convexes ou concaves

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.


Classification kind code

11

Mark Details


Serial Number

2142535

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 25th Oct 2023
Advertised
Submitted for opposition 27
on 27th Sept 2023
Approval Notice Sent
Submitted for opposition 26
on 27th Sept 2023
Approved
Submitted for opposition 135
on 6th Sept 2023
Amendment to Application
Submitted for opposition 22
on 21st Mar 2023
Search Recorded
Submitted for opposition 20
on 21st Mar 2023
Examiner's First Report
Submitted for opposition 287
on 17th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 25th Oct 2021
Filed
Submitted for opposition 1
on 25th Oct 2021
Created
Submitted for opposition 31
on 25th Oct 2021
Formalized